Philip Morris International (PM) Barclays 19th Annual Global Consumer Conference summary
Event summary combining transcript, slides, and related documents.
Barclays 19th Annual Global Consumer Conference summary
8 Sep, 2026Strategic and Financial Outlook
2026 adjusted diluted EPS forecast raised to $8.35–$8.50, reflecting 10.7%–12.7% growth, including a favorable currency impact of $0.24 per share, with Q3 seeing a $0.01 benefit at current rates.
Adjusted diluted EPS excluding currency projected at $8.11–$8.26, representing 7.5%–9.5% growth over 2025.
Sustained low double-digit EPS growth is targeted mid-term, supported by total volume growth and pricing power in both combustibles and smoke-free products.
Dividend remains the top capital allocation priority, with share buybacks under consideration as leverage targets are met.
Currency fluctuations and regulatory changes are actively managed through pricing and strategic flexibility.
Market and Product Developments
Japan's market is adapting to significant excise-driven price increases, with heated tobacco now exceeding 50% of nicotine market volume.
IQOS maintains a premium position despite competitive pricing tactics and is expected to resume growth as tax equalization with cigarettes improves margins.
U.S. market focus includes expanding ZYN with new moist and higher-nicotine SKUs, aiming for portfolio symmetry and value through larger can sizes, with Q4 transition of 3mg and 6mg dry variants to 20 pouches per can.
Regulatory clarity from the FDA on ZYN supports future planning, while IQOS ILUMA awaits PMTA authorization for U.S. launch.
Strong multicategory growth internationally, including VEEV and ZYN brands.
Category and Geographic Expansion
Smoke-free products drive growth, with multi-category strategies and new launches in markets like Taiwan and Argentina.
U.S. is seen as the most attractive growth opportunity due to its size and profitability in the nicotine space.
Combustible volumes remain robust in markets lacking smoke-free alternatives, with focus on opening new geographies.
Ongoing investment in marketing and brand-building, especially for ZYN, is expected to support further share gains.
Robust performance from combustibles continues, especially in markets with SFP bans or limited presence.
Latest events from Philip Morris International
- Smoke-free products drive robust growth, profitability, and superior shareholder returns.PM
Conference presentation - Double-digit adjusted EPS and revenue growth, but reported EPS down on RBH impairment.PM
Q2 2026 - Smoke-free products and innovation drive growth, with ZYN and IQOS leading global expansion.PM
Morgan Stanley Global Consumer & Retail Conference 2025 - Smoke-free products drive growth, with ZYN ULTRA and IQOS expanding amid regulatory progress.PM
23rd annual dbAccess Global Consumer Conference - Strong financial and smoke-free growth, dividend increase, and all board proposals but one approved.PM
AGM 2026 - 2025 EPS guidance targets 13–15% growth, led by robust smoke-free product expansion and margin gains.PM
Barclays 18th Annual Global Consumer Staples Conference 2025 - Raised 2024 guidance after record H1 growth, led by IQOS and ZYN, with margin expansion.PM
Q2 2024 - Smoke-free product momentum and raised EPS guidance highlight strong 2024 growth outlook.PM
21st Annual dbAccess Global Consumer Conference - Smoke-free product momentum and multi-category strategy drive robust 2025 financial outlook.PM
2025 dbAccess Global Consumer Conference